« Back
Home /
RC-3095

RC-3095

Item no.	DCC-DC21560-5mg
Manufacturer	DCChemicals
CASRN	138147-78-1
Amount	5 mg
Quantity options	10 mg 25 mg 50 mg 5 mg
Category	In Vivo Reagents & Chemicals Molecules
Type	Chemicals
Applications	IV
Specific against	other
Smiles	NC(CC[C@@H](C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](CN[C@H](C(=O)N)CC(C)C)CC(C)C)=O)CC1=CN=CN1)=O)=O)C(C)C)=O)C)=O)=O)NC([C@@H]1NCC2=C(C3=CC=CC=C3N2)C1)=O)=O.FC(C(=O)O)(F)F
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Manufacturer - Applications	RC-3095 is a gastrin-releasing peptide receptor antagonist, synergizes with gemcitabine to inhibit the growth of human pancreatic cancer CFPAC-1 in vitro and in vivo. RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. RC3095 inhibits tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.R, BRS-1) antagonist.
Molecular Weight	1220, 34492301941

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time